Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide

PURPOSE: Leflunomide (LEF) is a disease-modifying antirheumatic drug used for treating rheumatoid arthritis (RA) and the action of which may be modified by sex hormones. The aim of this study was to examine the association between CAG repeat polymorphism in the androgen receptor (AR) gene and the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziedziejko, Violetta, Kurzawski, Mateusz, Safranow, Krzysztof, Ossowski, Andrzej, Piatek, Jaroslaw, Parafiniuk, Miroslaw, Chlubek, Dariusz, Pawlik, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303044/
https://www.ncbi.nlm.nih.gov/pubmed/21997404
http://dx.doi.org/10.1007/s00228-011-1131-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303044/
https://www.ncbi.nlm.nih.gov/pubmed/21997404
http://dx.doi.org/10.1007/s00228-011-1131-3

Ejemplares similares